These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 23890519)

  • 1. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
    Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R
    Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2.
    Loomba-Albrecht LA; Jame M; Bremer AA
    Diabetes Res Clin Pract; 2010 Mar; 87(3):e23-5. PubMed ID: 20015564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
    García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
    Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
    Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
    Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
    Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
    Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase.
    Gutierrez-Nogués A; García-Herrero CM; Oriola J; Vincent O; Navas MA
    Biochim Biophys Acta Mol Basis Dis; 2018 Jul; 1864(7):2385-2394. PubMed ID: 29704611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes.
    Lu M; Li C
    Ann N Y Acad Sci; 2018 Jan; 1411(1):65-82. PubMed ID: 29044608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
    Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
    Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene.
    Barbetti F; Cobo-Vuilleumier N; Dionisi-Vici C; Toni S; Ciampalini P; Massa O; Rodriguez-Bada P; Colombo C; Lenzi L; Garcia-Gimeno MA; Bermudez-Silva FJ; Rodriguez de Fonseca F; Banin P; Aledo JC; Baixeras E; Sanz P; Cuesta-Muñoz AL
    Mol Endocrinol; 2009 Dec; 23(12):1983-9. PubMed ID: 19884385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
    Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
    J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting glucokinase activation for the treatment of type 2 diabetes--a status review.
    Sarabu R; Grimsby J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):631-7. PubMed ID: 16159025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MODY2 caused by a novel mutation of GCK gene.
    Pulst K; Arbo T; Kahre T; Peet A; Tillmann V
    J Pediatr Endocrinol Metab; 2012; 25(7-8):801-3. PubMed ID: 23155715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene.
    Bennett K; James C; Mutair A; Al-Shaikh H; Sinani A; Hussain K
    Pediatr Diabetes; 2011 May; 12(3 Pt 1):192-6. PubMed ID: 21518409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GKAs for diabetes therapy: why no clinically useful drug after two decades of trying?
    Matschinsky FM
    Trends Pharmacol Sci; 2013 Feb; 34(2):90-9. PubMed ID: 23305809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
    Sagen JV; Odili S; Bjørkhaug L; Zelent D; Buettger C; Kwagh J; Stanley C; Dahl-Jørgensen K; de Beaufort C; Bell GI; Han Y; Grimsby J; Taub R; Molven A; Søvik O; Njølstad PR; Matschinsky FM
    Diabetes; 2006 Jun; 55(6):1713-22. PubMed ID: 16731834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in phenotype of hyperinsulinism caused by activating glucokinase mutations: a novel mutation and its functional characterization.
    Martínez R; Gutierrez-Nogués Á; Fernández-Ramos C; Velayos T; Vela A; ; Navas MÁ; Castaño L
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):778-783. PubMed ID: 28247534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
    Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.